CTOs on the Move

Innovative Medical Device Solutions (IMDS)

www.imds.net

 
IMDS (Innovative Medical Device Solutions) provides comprehensive product development and supply chain management solutions for medical device companies, with a focus on the orthopedic industry. IMDS is the integration of the following companies: Leis
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imds.net
  • 13600 Heritage Pkwy Ste 170
    Fort Worth, TX USA 76177
  • Phone: 877.583.0677

Executives

Name Title Contact Details

Similar Companies

Palisades Medical Center

Palisades Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Palisades Medical Center is based in North Bergen, NJ. You can find more information on Palisades Medical Center at www.palisadesmedical.org

Touchstone Health Partnership

Touchstone Health Partnership is a White Plains, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health at Home

Health at Home is a Delray Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Monogram Health

Our name, Monogram, symbolizes the personalized focus of our services. While the application of the latest technology and data science is critical to our success, we never lose sight that healthcare is ultimately about trusted individual relationships between healthcare professionals and their patients. Unfortunately, individuals living with advanced CKD and ESRD are negatively impacted by well entrenched systematic forces such as perverse economic incentives, poor adherence to evidence-based care, and a lack of sensitivity to the negative impacts of social determinants of health. The 21st Century Cures Act is a seminal piece of legislation designed to shift individuals living with ESRD from FFS Medicare into managed care and reverse decades and decades of sub-optimal outcomes. Monogram was born with a vision to serve health plans and other sponsors of health care and solve for these systemic problems. Our mission is to improve clinical outcomes by predicting the onset of CKD and ESRD, slowing its progression, and reducing hospitalizations, morbidity and mortality. We are founded and operated by a core group of former government programs health plan executives, including our CEO, Michael Uchrin, a world-renown nephrologist and author of over 200 published pieces of research, Dr. Raymond Hakim, and former US Senator Bill Frist M.D., a retired cardiac surgeon and recognized leader for improving the quality of care provided to human beings across the world. We welcome all stakeholders in the CKD | ESRD ecosystem to join us in our mission to measurably improve outcomes for individuals living with these conditions.